These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
190 related articles for article (PubMed ID: 22343321)
1. Cancer stem-like cells contribute to cisplatin resistance and progression in bladder cancer. Zhang Y; Wang Z; Yu J; Shi Jz; Wang C; Fu Wh; Chen Zw; Yang J Cancer Lett; 2012 Sep; 322(1):70-7. PubMed ID: 22343321 [TBL] [Abstract][Full Text] [Related]
2. Knockdown of Bmi1 inhibits the stemness properties and tumorigenicity of human bladder cancer stem cell-like side population cells. Zhu D; Wan X; Huang H; Chen X; Liang W; Zhao F; Lin T; Han J; Xie W Oncol Rep; 2014 Feb; 31(2):727-36. PubMed ID: 24337040 [TBL] [Abstract][Full Text] [Related]
3. Ursolic acid inhibits the proliferation of human ovarian cancer stem-like cells through epithelial-mesenchymal transition. Zhang J; Wang W; Qian L; Zhang Q; Lai D; Qi C Oncol Rep; 2015 Nov; 34(5):2375-84. PubMed ID: 26323892 [TBL] [Abstract][Full Text] [Related]
4. Markedly increased Oct4 and Nanog expression correlates with cisplatin resistance in oral squamous cell carcinoma. Tsai LL; Yu CC; Chang YC; Yu CH; Chou MY J Oral Pathol Med; 2011 Sep; 40(8):621-8. PubMed ID: 21342274 [TBL] [Abstract][Full Text] [Related]
5. Side population cells separated from A549 lung cancer cell line possess cancer stem cell-like properties and inhibition of autophagy potentiates the cytotoxic effect of cisplatin. Yang Y; Fan Y; Qi Y; Liu D; Wu K; Wen F; Zhao S Oncol Rep; 2015 Aug; 34(2):929-35. PubMed ID: 26081992 [TBL] [Abstract][Full Text] [Related]
6. Targeting an Autocrine Regulatory Loop in Cancer Stem-like Cells Impairs the Progression and Chemotherapy Resistance of Bladder Cancer. Wang KJ; Wang C; Dai LH; Yang J; Huang H; Ma XJ; Zhou Z; Yang ZY; Xu WD; Hua MM; Lu X; Zeng SX; Wang HQ; Zhang ZS; Cheng YQ; Liu D; Tian QQ; Sun YH; Xu CL Clin Cancer Res; 2019 Feb; 25(3):1070-1086. PubMed ID: 30397177 [TBL] [Abstract][Full Text] [Related]
7. Cancer stem-like cells can be isolated with drug selection in human ovarian cancer cell line SKOV3. Ma L; Lai D; Liu T; Cheng W; Guo L Acta Biochim Biophys Sin (Shanghai); 2010 Sep; 42(9):593-602. PubMed ID: 20705681 [TBL] [Abstract][Full Text] [Related]
8. shRNA targeting Bmi1 impedes the self-renewal of cisplatin-enriched stem-like cells in human A549 cells. Xu Y; Hu YD; Zhou J; Zhang MH; Yuan WW; Luo Y Oncol Rep; 2012 Aug; 28(2):629-39. PubMed ID: 22664532 [TBL] [Abstract][Full Text] [Related]
10. Upregulated expression of BCL2, MCM7, and CCNE1 indicate cisplatin-resistance in the set of two human bladder cancer cell lines: T24 cisplatin sensitive and T24R2 cisplatin resistant bladder cancer cell lines. Kim SH; Ho JN; Jin H; Lee SC; Lee SE; Hong SK; Lee JW; Lee ES; Byun SS Investig Clin Urol; 2016 Jan; 57(1):63-72. PubMed ID: 26966728 [TBL] [Abstract][Full Text] [Related]
11. Cisplatin induces stemness in ovarian cancer. Wiechert A; Saygin C; Thiagarajan PS; Rao VS; Hale JS; Gupta N; Hitomi M; Nagaraj AB; DiFeo A; Lathia JD; Reizes O Oncotarget; 2016 May; 7(21):30511-22. PubMed ID: 27105520 [TBL] [Abstract][Full Text] [Related]
12. Silibinin inhibits β-catenin/ZEB1 signaling and suppresses bladder cancer metastasis via dual-blocking epithelial-mesenchymal transition and stemness. Wu K; Ning Z; Zeng J; Fan J; Zhou J; Zhang T; Zhang L; Chen Y; Gao Y; Wang B; Guo P; Li L; Wang X; He D Cell Signal; 2013 Dec; 25(12):2625-33. PubMed ID: 24012496 [TBL] [Abstract][Full Text] [Related]
13. Self-renewal and chemotherapy resistance of p75NTR positive cells in esophageal squamous cell carcinomas. Huang SD; Yuan Y; Liu XH; Gong DJ; Bai CG; Wang F; Luo JH; Xu ZY BMC Cancer; 2009 Jan; 9():9. PubMed ID: 19134212 [TBL] [Abstract][Full Text] [Related]
14. Nanog regulates self-renewal of cancer stem cells through the insulin-like growth factor pathway in human hepatocellular carcinoma. Shan J; Shen J; Liu L; Xia F; Xu C; Duan G; Xu Y; Ma Q; Yang Z; Zhang Q; Ma L; Liu J; Xu S; Yan X; Bie P; Cui Y; Bian XW; Qian C Hepatology; 2012 Sep; 56(3):1004-14. PubMed ID: 22473773 [TBL] [Abstract][Full Text] [Related]
15. Sonic hedgehog (Shh) signaling promotes tumorigenicity and stemness via activation of epithelial-to-mesenchymal transition (EMT) in bladder cancer. Islam SS; Mokhtari RB; Noman AS; Uddin M; Rahman MZ; Azadi MA; Zlotta A; van der Kwast T; Yeger H; Farhat WA Mol Carcinog; 2016 May; 55(5):537-51. PubMed ID: 25728352 [TBL] [Abstract][Full Text] [Related]
16. Role of BMI1, a stem cell factor, in cancer recurrence and chemoresistance: preclinical and clinical evidences. Siddique HR; Saleem M Stem Cells; 2012 Mar; 30(3):372-8. PubMed ID: 22252887 [TBL] [Abstract][Full Text] [Related]
17. Aberrant DNA methylation of T-cell leukemia, homeobox 3 modulates cisplatin sensitivity in bladder cancer. Tada Y; Yokomizo A; Shiota M; Tsunoda T; Plass C; Naito S Int J Oncol; 2011 Sep; 39(3):727-33. PubMed ID: 21617853 [TBL] [Abstract][Full Text] [Related]
18. Coexpression of gene Oct4 and Nanog initiates stem cell characteristics in hepatocellular carcinoma and promotes epithelial-mesenchymal transition through activation of Stat3/Snail signaling. Yin X; Zhang BH; Zheng SS; Gao DM; Qiu SJ; Wu WZ; Ren ZG J Hematol Oncol; 2015 Mar; 8():23. PubMed ID: 25879771 [TBL] [Abstract][Full Text] [Related]
19. Reduced tumorigenicity and drug resistance through the downregulation of octamer-binding protein 4 and Nanog transcriptional factor expression in human breast stem cells. Huang ZJ; You J; Luo WY; Chen BS; Feng QZ; Wu BL; Jiang L; Luo Q Mol Med Rep; 2015 Mar; 11(3):1647-54. PubMed ID: 25405855 [TBL] [Abstract][Full Text] [Related]
20. Direct activation of Bmi1 by Twist1: implications in cancer stemness, epithelial-mesenchymal transition, and clinical significance. Wu KJ Chang Gung Med J; 2011; 34(3):229-38. PubMed ID: 21733352 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]